Child’s Ordeal Shows Dangers of Antipsychotic Drugs - NYTimes.com
OPELOUSAS, La. — At 18 months, Kyle Warren started taking a daily antipsychotic drug on the orders of a pediatrician trying to quell the boy’s severe temper tantrums.
Thus began a troubled toddler’s journey from one doctor to another, from one diagnosis to another, involving even more drugs. Autism, bipolar disorder, hyperactivity, insomnia, oppositional defiant disorder. The boy’s daily pill regimen multiplied: the antipsychotic Risperdal, the antidepressant Prozac, two sleeping medicines and one for attention-deficit disorder. All by the time he was 3.
He was sedated, drooling and overweight from the side effects of the antipsychotic medicine. Although his mother, Brandy Warren, had been at her “wit’s end” when she resorted to the drug treatment, she began to worry about Kyle’s altered personality. “All I had was a medicated little boy,” Ms. Warren said. “I didn’t have my son. It’s like, you’d look into his eyes and you would just see just blankness.”
Continue reading: http://www.nytimes.com/2010/09/02/business/02kids.html
Codex: Yes to Malnutrition
Our thanks go to the National Health Federation and Scott Tips for his shattering report on the recent CODEX deliberations in Germany. You should too.As these government directed pundits go you see for the most part that not only do they have no understanding of nutrients and nutrition Readmore...
UDOH Looking flr People Ready to Quit Tobacco
The Utah Department of Health (UDOH) today released the Utah Hospital Comparison Report, 2011. Utahns can use the report to access important information on all Utah hospitals regarding quality and patient safety measures that include:1. Rates of accidental lacerations and punctures;2. Death rates for diagnoses that should rarely result in death (e.g., hip dislocation, cesarean delivery);3 Readmore..
How fruit and veg can beat breast cancer
London Nutritionist Yvonne Bishop-Weston said today "New laws forbid nutritionists to say or do anything that may encourage patients to forgo their standard treatment and seek an alternative treatment or even a diet so it's hard to honestly and freely comment on these studies"t Readmore...
Child’s Ordeal Shows Risks of Psychosis Drugs for Young
Child’s Ordeal Shows Risks of Psychosis Drugs for Young
Child’s Ordeal Shows Dangers of Antipsychotic Drugs - NYTimes.com
OPELOUSAS, La. — At 18 months, Kyle Warren started taking a daily antipsychotic drug on the orders of a pediatrician trying to quell the boy’s severe temper tantrums.
Thus began a troubled toddler’s journey from one doctor to another, from one diagnosis to another, involving even more drugs. Autism, bipolar disorder, hyperactivity, insomnia, oppositional defiant disorder. The boy’s daily pill regimen multiplied: the antipsychotic Risperdal, the antidepressant Prozac, two sleeping medicines and one for attention-deficit disorder. All by the time he was 3.
He was sedated, drooling and overweight from the side effects of the antipsychotic medicine. Although his mother, Brandy Warren, had been at her “wit’s end” when she resorted to the drug treatment, she began to worry about Kyle’s altered personality. “All I had was a medicated little boy,” Ms. Warren said. “I didn’t have my son. It’s like, you’d look into his eyes and you would just see just blankness.”
Continue reading: http://www.nytimes.com/2010/09/02/business/02kids.html
Margarine Not Heart Healthy
from Natural Health NewsUnilever: Omega-3 margarine study will not affect usage advice
By Shane Starling, 31-Aug-2010
Related topics: Nutritional lipids and oils, Cardiovascular health
Omega-3 spread maker Unilever says a 40 month study that found omega-3 spreads don’t protect elderly heart attack sufferers from further cardiac events, requires further analysis and won’t affect approved methods of usage.“The outcome does not question the current authoritative dietary recommendations and advices for omega 3 intakes on which our products are based,” Unilever’s Flip Dotsch told NutraIngredients.com this morning.The ALPHA-OMEGA trial saw almost 5000, 60-80 year old male and female heart attack survivors consuming varying levels of EPA (eicosapentaenoic acid), DHA (docosahexaenoic acid) and ALA (alpha-linolenic acid) via non-commercial Unilever omega-3 spreads developed for the study for 40 months.One group consumed 376mg of marine sourced DHA and EPA; another had 1.9g of soy and walnut sourced ALA; a third group had a spread fortified with all three fatty acids and a fourth was placebo.After the 40 months, 13.9 per cent of the participants, who were 75 per cent male and 24 per cent obese, had suffered another cardiac event among all the groups.SurprisingUnsurprisingly, Unilever said it found the results surprising, especially when the body of EPA/DHA scientific literature was considered.“The study outcome for EPA and DHA is surprising considering the weight of evidence published to date,” Unilever said in a statement. “This could be the result of methodological issues such as the relatively low daily dosage compared to previous studies or the fact that in this study serious cardiovascular events were much lower than in studies performed in the past. This is probably due to extensive drug treatment that is nowadays applied.”It said its “science experts” were looking at the paper in greater detail.The European Food Safety Authority has issued opinion on ALA, saying it supports lowering of blood cholesterol, But EPA/DHA were not backed for the same effect in an opinion published in October 2009.No effectLead researcher, Daan Kromhout, PhD, of Wageningen University in the Netherlands, said that while the study found omega-3 fatty acid-enriched margarines "had no effect on the rate of major cardiovascular events”,improvements in medical treatment could have been a factor.The EPA-DHA daily dose of 400mg was half that recommended by the American Heart Association.Kromhout noted "the patients in this trial were very well treated" with many taking blood pressure and cholesterol drugs, a factor that made, “beneficial effect of low doses of EPA-DHA difficult to prove."The findings were presented at the European Society of Cardiology Congress and simultaneously published in theNew England Journal of Medicine.Unilever added: “We welcome this well-executed study as a valuable addition to the growing body of evidence on the role of omega 3s in cardiovascular health. Unilever is proud to have supported this important study and has a long history of supporting scientific investigation into cardiovascular disease and its management through diet and lifestyle.”Source: New England Journal of Medicine‘n–3 Fatty Acids and Cardiovascular Events after Myocardial Infarction’10.1056/nejmoa1003603Authors: Daan Kromhout, M.P.H., PhD, Erik J. Giltay, M.D., PhD, Johanna M. Geleijnse, PhD© 2000/2010 - Decision News Media SAS - All right reserved
Margarine Not Heart Healthy
from Natural Health NewsUnilever: Omega-3 margarine study will not affect usage advice
By Shane Starling, 31-Aug-2010
Related topics: Nutritional lipids and oils, Cardiovascular health
Omega-3 spread maker Unilever says a 40 month study that found omega-3 spreads don’t protect elderly heart attack sufferers from further cardiac events, requires further analysis and won’t affect approved methods of usage.“The outcome does not question the current authoritative dietary recommendations and advices for omega 3 intakes on which our products are based,” Unilever’s Flip Dotsch told NutraIngredients.com this morning.The ALPHA-OMEGA trial saw almost 5000, 60-80 year old male and female heart attack survivors consuming varying levels of EPA (eicosapentaenoic acid), DHA (docosahexaenoic acid) and ALA (alpha-linolenic acid) via non-commercial Unilever omega-3 spreads developed for the study for 40 months.One group consumed 376mg of marine sourced DHA and EPA; another had 1.9g of soy and walnut sourced ALA; a third group had a spread fortified with all three fatty acids and a fourth was placebo.After the 40 months, 13.9 per cent of the participants, who were 75 per cent male and 24 per cent obese, had suffered another cardiac event among all the groups.SurprisingUnsurprisingly, Unilever said it found the results surprising, especially when the body of EPA/DHA scientific literature was considered.“The study outcome for EPA and DHA is surprising considering the weight of evidence published to date,” Unilever said in a statement. “This could be the result of methodological issues such as the relatively low daily dosage compared to previous studies or the fact that in this study serious cardiovascular events were much lower than in studies performed in the past. This is probably due to extensive drug treatment that is nowadays applied.”It said its “science experts” were looking at the paper in greater detail.The European Food Safety Authority has issued opinion on ALA, saying it supports lowering of blood cholesterol, But EPA/DHA were not backed for the same effect in an opinion published in October 2009.No effectLead researcher, Daan Kromhout, PhD, of Wageningen University in the Netherlands, said that while the study found omega-3 fatty acid-enriched margarines "had no effect on the rate of major cardiovascular events”,improvements in medical treatment could have been a factor.The EPA-DHA daily dose of 400mg was half that recommended by the American Heart Association.Kromhout noted "the patients in this trial were very well treated" with many taking blood pressure and cholesterol drugs, a factor that made, “beneficial effect of low doses of EPA-DHA difficult to prove."The findings were presented at the European Society of Cardiology Congress and simultaneously published in theNew England Journal of Medicine.Unilever added: “We welcome this well-executed study as a valuable addition to the growing body of evidence on the role of omega 3s in cardiovascular health. Unilever is proud to have supported this important study and has a long history of supporting scientific investigation into cardiovascular disease and its management through diet and lifestyle.”Source: New England Journal of Medicine‘n–3 Fatty Acids and Cardiovascular Events after Myocardial Infarction’10.1056/nejmoa1003603Authors: Daan Kromhout, M.P.H., PhD, Erik J. Giltay, M.D., PhD, Johanna M. Geleijnse, PhD© 2000/2010 - Decision News Media SAS - All right reserved
Animal testing continues...
Companies that (still) test on animals
A shocking number of manufacturers of personal care and household items still test their products on animals, despite the availability of alternative methods for evaluating product safety. Here is the most recent list of these companies and their associated brands, with some of the biggest shockers in red. We gathered this information from the vegetarian site.com and original sources are referenced below. Please choose all-natural products to help put an end to this insane animal cruelty!
Animal testing continues...
Companies that (still) test on animals
A shocking number of manufacturers of personal care and household items still test their products on animals, despite the availability of alternative methods for evaluating product safety. Here is the most recent list of these companies and their associated brands, with some of the biggest shockers in red. We gathered this information from the vegetarian site.com and original sources are referenced below. Please choose all-natural products to help put an end to this insane animal cruelty!
Animals give GM the thumbs down
- During days 0-18, the GM maize grain-fed chickens consumed nine grams more than the natural maize-fed group, but during days 18-32 their consumption fell to seven grams less. During days 32-42 their consumption fell even further, to 63 grams less than that of the natural maize-fed group
- Whereas the final average body weights and total feed intakes of the GM- and natural maize-fed chickens were not very different, there was a much wider range in individual weights and intakes amongst the GM-fed birds, suggesting that at least some of them were not thriving on the GM maize
- Death rates during the trial in the two groups were reported to be “similar”. In fact, the average death rate in the GM-fed chickens (7.14%) was double that in the natural maize-fed chickens (3.57%)
Diet 2. 100% PAT
Diet 3. 100% SOY
Diet 4. The standard diet for laboratory rats
- Whereas the male rats eating low amounts of PAT (diets 1,3 and 4) maintained similar weights, the average weight of the male rats on diet 2 fell from being the highest to the lowest of all the male groups
- The average weights of the female rats fed either low or high amounts of PAT (diets 1 and 2), heaviest at the outset, fell below those of the females not eating PAT (diets 3 and 4)
- Both male and female rats consuming high amounts of PAT (diet 2) achieved lower weight gains per day, averaged over the 14 days, than those of their counterparts eating diets containing low or no PAT (diets 3 and 4)
- “By feeding purified PAT protein, rather than the whole maize plant (as it would be fed to cattle), this experiment is specifically designed to not detect any unpredicted effects
- “I do not consider that this study using rats can be used as a basis for making judgements about the safety of Chardon LL maize with respect to cattle”
[ 2] Dr Vyvyan Howard, Senior Lecturer and Head of the Foetal and Infant Toxicopathology Group at the University of Liverpool, and Fellow of the Royal College of Pathologists (18.10.2000)
[ 3] reported by the then Ministry of Agriculture, Fisheries and Food 10.11.00